ACA
HURA

Affinity Capital Advisors’s TuHURA Biosciences HURA Stock Holding History

Affinity Capital Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$2K – 114
2022
Q3 		$2K Buy
13
+2
+18% +$639 ﹤0.01% 108
2022
Q2 		$5K Buy
+11
New +$4.79K ﹤0.01% 109

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Affinity Capital Advisors's HURA Position: Q4 2022 in Review

Affinity Capital Advisors sold out of TuHURA Biosciences (HURA) in Q4 2022, closing a stake of 13 shares — an estimated $2K sold.

Affinity Capital Advisors first reported a position in HURA in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q2 2022. 10 funds tracked by Wall St. Rank hold HURA as of Q4 2022.

  • Affinity Capital Advisors reported no remaining TuHURA Biosciences position as of Q4 2022 after selling out during the quarter.
  • Affinity Capital Advisors sold 13 TuHURA Biosciences shares in Q4 2022, an estimated $2K.
  • Affinity Capital Advisors first reported a position in TuHURA Biosciences in Q2 2022 and held it in 2 quarters.
  • Affinity Capital Advisors's TuHURA Biosciences position peaked at $5K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2022.

Based on Affinity Capital Advisors's 13F filing for Q4 2022, filed 19 Jan 2023.